Human EGFR Gene Mutation Detection Assays

Molecular assay reagents (primers and probes) that detect EGFR gene mutations in tissue DNA and plasma cfDNA, including the EGFR-19del variant common in Asian non-small cell lung cancer patients.

Real-time PCR, strip-based, and next-generation sequencing assays for detecting and identifying genetic mutations. These diagnostic tools enable rapid mutation analysis for genomic screening, disease stratification, and personalized medicine applications. Suitable for clinical laboratories and research settings requiring high-sensitivity genetic variant detection.

Molecular assay kit detecting EGFR gene mutations including EGFR-19del variant in tissue DNA and plasma cell-free DNA. Supports non-small cell lung cancer patient stratification and treatment selection.

This kit is used to in vitro qualitatively detect common mutations in exons 18-21 of the EGFR gene in samples from human non-small cell lung cancer patients.

A reagent kit designed for the combined detection of human EGFR and ALK gene mutations. The kit is used for molecular testing to identify specific genetic mutations in patient samples.

PCR-based molecular diagnostic kit for detection of epidermal growth factor receptor mutations in solid tumors. Supports personalized cancer treatment planning and targeted therapy selection.

A real-time PCR diagnostic kit for EGFR mutation detection. Used in solid tumour oncology for identifying epidermal growth factor receptor mutations in patient samples.

Assays for measuring gene expression and functional outcomes. Used in molecular diagnostics, research, and therapeutic monitoring applications.

Sensitive detection of epidermal growth factor receptor mutations in lung cancer specimens. Identifies patients eligible for targeted tyrosine kinase inhibitor therapy.

An in vitro diagnostic reagent kit for qualitative detection of EGFR and ALK gene mutations in non-small cell lung cancer (NSCLC). The kit has received Class III medical device registration certification from the National Medical Products Administration and is used for clinical diagnosis in hospitals nationwide.

Molecular test for detection of epidermal growth factor receptor mutations in lung cancer diagnosis.

Genetic testing assays for hereditary disease screening and molecular diagnostics.